PROCEPT BIOROBOTICS CORP (PRCT)

First Week of PRCT July 2025 Options Trading

Investors Land PRCT Even Cheaper Than Its Secondary Stock Offering

PROCEPT BioRobotics Corporation Announces Pricing of Offering of Common Stock

PROCEPT BioRobotics Corporation Announces Pricing of Offering of Common Stock

SAN JOSE, Calif., Oct. 29, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (NASDAQ: PRCT) (“PROCEPT BioRobotics” or the “Company”), a surgical...

Royal Caribbean Sails Onto The IBD 50: Build Your List Of Stocks To Watch With These Top IBD Screens

Royal Caribbean earns its spot on the Big Cap 20 with a best-possible 99 Composite Rating, putting it in the top 1% of all stocks.

PROCEPT BioRobotics Corporation Announces Proposed Offering of Common Stock

PROCEPT BioRobotics Corporation Announces Proposed Offering of Common Stock

SAN JOSE, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (NASDAQ: PRCT) (“PROCEPT BioRobotics” or the “Company”), a surgical...

Procept Biorobotics, A Top 5% Stock, Makes A Bullish Move On Quarterly Beat And Raise

The company sells systems that perform aquablation to treat enlarged prostates.

PROCEPT BioRobotics® Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance

Deborah Kilpatrick Joins Sonder Capital as its Newest Venture Partner

/PRNewswire/ -- Sonder Capital, a leading healthcare venture firm focused on innovative technologies ushering in a new standard of care in medicine, announced...

PROCEPT BioRobotics® Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance

SAN JOSE, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused...

Notable Tuesday Option Activity: GXO, PENN, PRCT

PROCEPT BioRobotics to Report Third Quarter 2024 Financial Results on October 28, 2024

PROCEPT BioRobotics to Report Third Quarter 2024 Financial Results on October 28, 2024

SAN JOSE, Calif., Oct. 09, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused...

PROCEPT BioRobotics Received U.S. FDA Approval to Initiate Pivotal Randomized Clinical Study for Prostate Cancer

PROCEPT BioRobotics Received U.S. FDA Approval to Initiate Pivotal Randomized Clinical Study for Prostate Cancer

A Prospective, Randomized, Multicenter Study Assessing the Safety and Efficacy of Aquablation Therapy in Men with Grade Group 1 to 3 Localized Prostate...

PROCEPT BioRobotics Becomes Oversold (PRCT)

PROCEPT BioRobotics to Present at Upcoming 2024 Wells Fargo Healthcare Conference on September 4, 2024

PROCEPT BioRobotics to Present at Upcoming 2024 Wells Fargo Healthcare Conference on September 4, 2024

SAN JOSE, Calif., Aug. 28, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing...

Noteworthy Wednesday Option Activity: SSTK, AMBA, PRCT

PROCEPT BioRobotics Announces FDA Clearance of the HYDROS™ Robotic System, the Next-Generation, AI-Powered Platform for Aquablation® Therapy

Designed to improve efficiency, enhance surgeon and staff experience and deliver a more accurate and consistent treatment plan for better clinical outcomes

PROCEPT BioRobotics Announces FDA Clearance of the HYDROS™ Robotic System, the Next-Generation, AI-Powered Platform for Aquablation® Therapy

Designed to improve efficiency, enhance surgeon and staff experience and deliver a more accurate and consistent treatment plan for better clinical...

3 Robotics Stocks to Sell in August Before They Crash & Burn

Discover which robotics stocks to sell in August and why, ensuring you avoid potential market downturns and secure your investments.

PROCEPT BioRobotics® Reports Second Quarter 2024 Financial Results and Increases 2024 Revenue and EBITDA Guidance

SAN JOSE, Calif., Aug. 01, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused...